{
  "id": 18004351,
  "title": "SDHB deficiency silences ABCB1 expression and confers therapeutic vulnerability across multiple cancer types",
  "url": "https://urgent.news/2026/11/03/sdhb-deficiency-silences-abcb1-expression-and-confers-therapeutic",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-03T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.29.761968v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Succinate dehydrogenase B (SDHB)-deficient cancers, including pheochromocytoma and paraganglioma (PPGL), renal cell carcinoma (RCC), and gastrointestinal stromal tumor (GIST), exhibit aggressive clinical behavior with limited treatment options. To identify novel therapeutic vulnerabilities, we performed high-throughput drug screening using co-cultured human SDHB-deficient and SDHB-reconstituted…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}